2024 Publication listこのページを印刷する - 2024 Publication list

2024 Publication list

　　2024年度（2024年4月―2025年3月）論文
  1. Okita R, Senoo T, Mimura-Kimura Y, Mimura Y, Murakami T, Ikeda E, Okada M, Inokawa H, Aoe K. Characterizing soluble immune checkpoint molecules and TGF-β1,2,3 in pleural effusion of malignant pleural mesothelioma. Scientific Reports 2024; 14(1):15947.
 
  1. Li C, Huang Y, Yi X, Tang Y, Okita R, He J. Pan-cancer prognostic model and immune microenvironment analysis of natural killer cell-related genes. Translational Cancer Research 2024; 13(4):1936-1953
 
  1. Matsubara K, Yamamoto H, Okita R, Otani S, Watanabe M, Ueno T, Mitsuhashi T, Tanaka T, Hiraki T, Toyooka S, Impact of C-Reactive Protein-to-Albumin ratio on lung cancer with interstitial pneumonia. Annals of Thoracic Surgery Short Reports 2024; 2(4):603-607.
 
  1. Kunihiro Y, Matsumoto T, Onoda H, Murakami T, Iduki M, Hirano Y, Ito K. A quantitative analysis of progressive fibrosing interstitial lung disease on computed tomography for the assessment of decreased vital capacity. Acta Radiologica 2024; 65(8): 922-929.
 
  1. Yamamoto T, Oishi K, Ohata S, Murata Y, Yamaji Y, Asami-Noyama M, Edakuni N, Kakugawa T, Hirano T, Matsunaga K, Management Reality of Female Patients with COPD: A multicenter cross-sectional CAP study in Japan. International Journal of Chronic Obstructive Pulmonary Disease 2024; 19: 1123-1130.
 
  1. Kakugawa T, Mimura Y, Mimura-Kimura Y, Doi K, Ohteru Y, Kakugawa H, Oishi K, Kakugawa M, Hirano T, Matsunaga K, Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in Japan. Immunity & Ageing 2024; 21(1):41.
 
  1. Karashima T, Mimura-Kimura Y, Mimura Y, Albuterol delivery via in-line intrapulmonary percussive ventilation superimposed on invasive ventilation in an adult lung model. Respiratory Care 2024; 69(9): 1092-1099.
 
  1. Yoh K, Azuma K, Hayashi H, Nishio M, Chikamori K, Ichihara E, Watanabe Y, Asato T, Kitagawa T, Fram RJ, Ohe Y, A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations. International Journal of Clinical Oncology 2024; 29(10):1461-1474.
 
  1. Kato Y, Udagawa H, Matsumoto S, Izumi H, Ohe Y, Kato T, Nishino K, Miyamoto S, Kawana S, Chikamori K, Shingyoji M, Sato Y, Takada Y, Toyozawa R, Azuma K, Tanaka Y, Sakai T, Shibata Y, Sugiyama E, Nosaki K, Zenke Y, Umemura S, Yoh K, Seike M, Goto K. Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia. Lung Cancer 2024: 197: 107992
 
  1. Matsumori, K, Hamada, K, Oishi, K, Okimura, M, Yonezawa, K, Watanabe, M, Hisamoto, Y, Murakawa, K, Fukatsu-Chikumoto, A, Matsuda, K, Ohata, S, Suetake, R, Utsunomiya, T, Murata, Y, Yamaji, Y, Asami-Noyama, M, Edakuni, N, Kakugawa, T, Hirano, T, Matsunaga, K. Relief of airflow limitation and airway inflammation by endoscopic sinus surgery in a patient with severe asthma with eosinophilic chronic rhinosinusitis. Internal Medicine 2024; 63(16):2317-2320.
 
  1. Miyauchi, E, Nishio, M, Ohashi, K, Osoegawa, A, Kikuchi, E, Kimura, H, Goto, Y, Shimizu, J, Yoshioka, H, Yoshino, I, Misumi, T, Katakami, N, Oki, M, Kijima, T, Chikamori, K, Nishino, K, Kobayashi, Y, Miwa, A, Tanaka, M, Gemma, A. J-TAIL-2: A prospective, observational study of atezolizumab combined with carboplatin and etoposide in patients with extensive-stage SCLC in Japan. JTO Clinical and Research Reports 2024; 6(3):100783.
 
  1. Hisamoto Y, Murata Y, Matsuda K, Narikiyo K, Kobayashi T, Yonezawa K, Murakawa K, Hamada K, Ohata S, Utsunomiya T, Yamaji Y, Oishi K, Asami-Noyama M, Edakuni N, Kakugawa T, Hirano T, Matsunaga K. Bucillamine-induced yellow nail syndrome with chylothorax: A case report. Internal Medicine 2025; 64(18): 2755-2759.
 
  1. 國弘佳枝、小林大河、亀田ふみ、田中伸幸、松本常男、亀井治人、伊東克能. 呼吸器のcommon diseaseにみる非典型的画像所見　細菌性肺炎. 画像診断2024; 44(9): 899-909.
 
  1. 國弘佳枝、伊東克能、田中伸幸. Q4. 肺真菌症の画像所見について教えてください.画像診断 2024; 45(1): 56-58.
 
  1. 國弘佳枝、伊東克能、田中伸幸. Q5. ニューモシスチス肺炎（PCP）とサイトメガロウィルス（CMV）肺炎の画像所見について教えてください. 画像診断2024; 45(1) 59-61.
 
  1. 國弘佳枝、伊東克能、田中伸幸. Q6. マイコプラズマ肺炎、新型コロナウイルス肺炎、インフルエンザウイルス肺炎の画像所見について教えてください. 画像診断 2024; 45(1): 62-64.
 
  1. 辛島隆司、三村由香、石本望実、中村亮裕、宮川奏、三村雄輔. 高頻度人工呼吸器2機種のエアロゾル噴霧能力と換気能力の比較. Japanese Journal of Respiratory Care 2024; 41(2): 226-229.
 
  1. 辛島隆司、中村亮裕. 当院におけるAerogen TM Soloの活用例. Japanese Journal of Respiratory Care 2024; 41(1): 137-138.
 
  1. 小笠原啓子、竹内愛、藤田浩美、村田佳代子、小嶋麻衣子、中冨雅子、佐伯達矢. がん呼吸器疾患専門病院におけるAdvance Care Planning (ACP)推進の取り組みと職員の意識の変化. 山口医学 2024; 73(4): 145-155.

 
ページトップへ